ARCHIVES

House Panel Recommends $642 Million Increase For NIH; $31 Million Increase For NCI

This article is from The Cancer Letter archive.

Vol. 21 No. 29 | July 21, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

In Brief: Clearinghouse Charter Renewed For Two Years; Good On China, Carbone On Communciation

May 26, 1978

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

In Brief: Tormey To Replace Carbone As ECOG chairman; Bishop Delivers First B.J. Kennedy Lecture

November 2, 1990

NIH Study Confirms Male Risk Factors For Breast Cancer

February 28, 2014

FDA Committee Approves NDA for Mitxantrone

March 21, 1986